• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢哌酮加舒巴坦与其他抗菌药物对厌氧菌的体外活性比较。

In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.

作者信息

Wexler H M, Finegold S M

机构信息

Medical Service, Veterans Administration Wadsworth Medical Center, Los Angeles, California 90073.

出版信息

Antimicrob Agents Chemother. 1988 Mar;32(3):403-6. doi: 10.1128/AAC.32.3.403.

DOI:10.1128/AAC.32.3.403
PMID:3364960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC172186/
Abstract

The activity of two cefoperazone-sulbactam combinations against anaerobic bacteria was tested and compared both with that of cefoperazone alone and with that of other commonly used antimicrobial agents. Imipenem was the most active of the tested agents, followed by chloramphenicol, metronidazole, and cefoperazone-sulbactam (90 to 100% of bacterial growth inhibited). Clindamycin and cefoxitin inhibited approximately 80%, cefoperazone inhibited 63%, and penicillin G inhibited 47% of the strains tested. The agents were variable in activity against the Bacteroides fragilis group, with percents susceptible as follows: cefoperazone-sulbactam, imipenem, metronidazole, and chloramphenicol, 99 to 100%; cefoxitin and clindamycin, approximately 80%; cefoperazone, 49%; and penicillin G, 15.5%.

摘要

测试了两种头孢哌酮 - 舒巴坦组合对厌氧菌的活性,并将其与单独使用头孢哌酮的活性以及其他常用抗菌剂的活性进行了比较。亚胺培南是测试药物中活性最强的,其次是氯霉素、甲硝唑和头孢哌酮 - 舒巴坦(抑制90%至100%的细菌生长)。克林霉素和头孢西丁抑制约80%的测试菌株,头孢哌酮抑制63%,青霉素G抑制47%。这些药物对脆弱拟杆菌属菌群的活性各不相同,敏感百分比如下:头孢哌酮 - 舒巴坦、亚胺培南、甲硝唑和氯霉素为99%至100%;头孢西丁和克林霉素约为80%;头孢哌酮为49%;青霉素G为15.5%。

相似文献

1
In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.头孢哌酮加舒巴坦与其他抗菌药物对厌氧菌的体外活性比较。
Antimicrob Agents Chemother. 1988 Mar;32(3):403-6. doi: 10.1128/AAC.32.3.403.
2
In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria.
Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):51-5. doi: 10.1016/0732-8893(90)90054-y.
3
[Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].氨苄西林、头孢哌酮及其与舒巴坦联合用药以及其他抗生素对厌氧菌的体外活性比较
Antibiot Khimioter. 1995 Apr;40(4):25-9.
4
Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.394株脆弱拟杆菌、非脆弱拟杆菌属拟杆菌种及梭杆菌属细菌对新型抗菌药物的敏感性
Antimicrob Agents Chemother. 1991 Jun;35(6):1214-8. doi: 10.1128/AAC.35.6.1214.
5
Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
J Antimicrob Chemother. 1992 Jan;29(1):57-67. doi: 10.1093/jac/29.1.57.
6
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.脆弱拟杆菌群物种及其他厌氧菌对美罗培南、亚胺培南、哌拉西林、头孢西丁、氨苄西林/舒巴坦、克林霉素和甲硝唑的敏感性比较。
J Antimicrob Chemother. 1993 Mar;31(3):363-72. doi: 10.1093/jac/31.3.363.
7
Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.
J Antimicrob Chemother. 1996 Oct;38(4):733-7. doi: 10.1093/jac/38.4.733.
8
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.头孢哌酮、头孢哌酮加舒巴坦、环丙沙星、克林霉素、甲硝唑及青霉素G在动物模型中对厌氧菌的比较疗效
J Lab Clin Med. 1990 Feb;115(2):190-5.
9
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Clin Infect Dis. 1995 Jun;20 Suppl 2:S356-60. doi: 10.1093/clinids/20.supplement_2.s356.
10
Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.厌氧菌对Sch 34343及其他β-内酰胺类抗生素的敏感性。
J Antimicrob Chemother. 1985 Jun;15 Suppl C:189-91. doi: 10.1093/jac/15.suppl_c.189.

引用本文的文献

1
Complex interaction of fasting glucose, body mass index, age and sex on all-cause mortality: a cohort study in 15 million Korean adults.空腹血糖、体重指数、年龄和性别对全因死亡率的复杂交互作用:一项对 1500 万韩国成年人的队列研究。
Diabetologia. 2020 Aug;63(8):1616-1625. doi: 10.1007/s00125-020-05160-1. Epub 2020 May 19.
2
Gram-positive anaerobic cocci.革兰氏阳性厌氧球菌
Clin Microbiol Rev. 1998 Jan;11(1):81-120. doi: 10.1128/CMR.11.1.81.
3
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.脆弱拟杆菌群各菌种对10种抗菌剂的敏感性。
Antimicrob Agents Chemother. 1990 Apr;34(4):671-3. doi: 10.1128/AAC.34.4.671.
4
Spiral gradient endpoint method compared to standard agar dilution for susceptibility testing of anaerobic gram-negative bacilli.螺旋梯度终点法与标准琼脂稀释法用于厌氧革兰氏阴性杆菌药敏试验的比较。
J Clin Microbiol. 1991 May;29(5):975-9. doi: 10.1128/jcm.29.5.975-979.1991.
5
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.β-内酰胺酶抑制剂对各种β-内酰胺类药物抗厌氧菌活性的影响。
Antimicrob Agents Chemother. 1991 Jun;35(6):1219-24. doi: 10.1128/AAC.35.6.1219.
6
Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.消化链球菌属对大环内酯类和林可酰胺类的耐药性:诱导型和组成型表型
Antimicrob Agents Chemother. 1992 Mar;36(3):662-4. doi: 10.1128/AAC.36.3.662.

本文引用的文献

1
In vitro susceptibility of anaerobic bacteria to nitroimidazoles.厌氧菌对硝基咪唑类药物的体外敏感性
Scand J Infect Dis Suppl. 1981;26:42-5.
2
Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections.从人类口腔面部感染患者中分离出与青霉素治疗临床失败相关的产β-内酰胺酶拟杆菌菌株。
Arch Oral Biol. 1980;25(10):689-92. doi: 10.1016/0003-9969(80)90102-8.
3
Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.克拉维酸对十种β-内酰胺类药物针对脆弱拟杆菌群成员活性的影响。
Antimicrob Agents Chemother. 1984 May;25(5):662-5. doi: 10.1128/AAC.25.5.662.
4
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.美国1292株脆弱拟杆菌属细菌的药敏情况:1981年与1982年的比较
Antimicrob Agents Chemother. 1984 Aug;26(2):145-8. doi: 10.1128/AAC.26.2.145.
5
Anaerobic bacteria and beta-lactam antibiotics.厌氧菌与β-内酰胺类抗生素
Scand J Infect Dis Suppl. 1984;42:72-82.
6
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.头孢哌酮与两种β-内酰胺酶抑制剂舒巴坦和克拉维酸对拟杆菌属的活性与β-内酰胺酶的产生相关。
Antimicrob Agents Chemother. 1982 Sep;22(3):398-405. doi: 10.1128/AAC.22.3.398.
7
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.头孢哌酮与β-内酰胺酶抑制剂联合应用的协同活性。
J Antimicrob Chemother. 1981 Mar;7(3):287-92. doi: 10.1093/jac/7.3.287.
8
Bacteroides gracilis, an important anaerobic bacterial pathogen.纤细拟杆菌,一种重要的厌氧细菌病原体。
J Clin Microbiol. 1985 Nov;22(5):799-802. doi: 10.1128/jcm.22.5.799-802.1985.
9
In vitro activity of cefbuperazone against anaerobic bacteria.头孢哌酮对厌氧菌的体外活性。
Antimicrob Agents Chemother. 1985 Apr;27(4):674-6. doi: 10.1128/AAC.27.4.674.
10
Antimicrobial resistance in Bacteroides.拟杆菌属中的抗菌药物耐药性。
J Antimicrob Chemother. 1987 Feb;19(2):143-6. doi: 10.1093/jac/19.2.143.